Richard Pzena’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Richard Pzena's REGN Position: Q3 2026 in Review
Richard Pzena opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 409 shares worth $310K. The stake represents ﹤0.01% of the portfolio and ranks #152 among its holdings. This is a return to the name: Richard Pzena previously reported a position in REGN as recently as Q3 2022.
Richard Pzena first reported a position in REGN in Q1 2021 and has held it in 8 quarters since. The position peaked at $661K in Q2 2022. 1,433 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Richard Pzena held 409 shares of Regeneron Pharmaceuticals worth $310K as of Q3 2026.
- Regeneron Pharmaceuticals was a new Richard Pzena position in Q3 2026.
- Regeneron Pharmaceuticals made up ﹤0.01% of Richard Pzena's portfolio in Q3 2026, its #152 holding.
- Richard Pzena first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 8 quarters since.
- Richard Pzena's Regeneron Pharmaceuticals position peaked at $661K in Q2 2022.
- 1,433 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Pzena Investment Management's 13F filing for Q3 2026, filed 30 Oct 2026.